New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
08:06 EDTDPRXDipexium Pharma' begins patient enrollment for clinical trial with Locilex
Dipexium Pharmaceuticals announced it has initiated patient enrollment in the second of two pivotal Phase 3 clinical trials, known as OneStep-1 and OneStep-2, evaluating Locilex, the company's novel, broad-spectrum, topical antibiotic peptide, for the treatment of patients with mild infections of diabetic foot ulcers, or Mild DFI. According to medical literature, approximately 47% of all patients with diabetic foot infections first present at the mild stage.
News For DPRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
07:33 EDTDPRXDipexium Pharmaceuticals reports FY14 EPS ($1.73), consensus ($1.88)

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use